Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Phase: N/A Priority: Normal
NCT ID: NCT00530764 Org: User:
Start: 11/30/07 End: 01/31/10 Due: 01/31/11

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01262651 Org: User:
Start: 11/25/10 End: 07/02/15 Due: 07/02/16

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02432612 Org: User:
Start: 10/31/15 End: 10/31/16 Due: 10/31/17

A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02240160 Org: User:
Start: 08/31/14 End: 10/31/15 Due: 10/31/16

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT01975688 Org: User:
Start: 02/28/14 End: 06/30/15 Due: 06/30/16

A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.

Phase: N/A Priority: Normal
NCT ID: NCT02325024 Org: User:
Start: 01/31/16 End: 10/31/16 Due: 10/31/17

Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

Phase: N/A Priority: Normal
NCT ID: NCT00391079 Org: User:
Start: 09/30/06 End: 09/30/08 Due: 09/30/09